Reports in Israel say that Medtronic (NYSE:MDT) has entered talks to acquire Triple Jump for $300 million.
Calcalist reported that the proposed acquisition, which is in advanced negotiations, follows a 2020 investment into Triple Jump made by Medtronic that also included an option to purchase the insulin pump maker.
Get the full story at our sister site, Drug Delivery Business News.